Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Illumina

Illumina

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina has developed a line of DNA sequencing technology products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.

Illumina Company Profile 

 

President & CEO: Francis deSouza

CEO photo:

illumina CEO Francis deSouza photo

Website: www.illumina.com

Ticker symbol: ILMN

Headquarters: San Diego, CA

Illumina employees: 5,500+ globally

Revenues: $2.4 Billion USD in 2016

Founded: 1998

Founders: Larry Bock, Anthony Czarnik, David Walt, Mark Chee, John Stuelpnagel

 

Illumina News 

May 22, 2020

Roche Acquires Sequencing Company Stratos Genomics

Roche said the acquisition is expected to advance development of its nanopore sequencer by providing access to Stratos' Sequencing by Expansion chemistry.

May 21, 2020

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

Premium

Single-cell analysis, next-generation sequencing, and synthetic DNA have all been crucial to efforts to find antibodies that could neutralize SARS-CoV-2.

May 15, 2020

Emerging COVID-19 Viral Genome Sequencing Assays Provide Alternative to Existing Diagnostics

Premium

Several groups are developing diagnostic viral genome sequencing assays and panels, which promise high sensitivity and additional information on viral origin and spread.

May 13, 2020

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium

The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.

May 13, 2020

Project to Sequence COVID-19 Patients

A UK consortium aims to sequence COVID-19 patients to uncover genetic variants that may contribute to disease susceptibility or severity.

May 12, 2020

Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal

The May 8 settlement resolves all claims and counterclaims relating to noninvasive prenatal testing and pre-implantation genetic screening and diagnosis.

May 12, 2020

Illumina, UK Agencies Partner on £28M Sequencing Study of COVID-19 Patients

Illumina will sequence 35,000 whole genomes for the Genetics of Mortality in Critical Care (GenOMICC) study and will provide an in-kind contribution.

May 08, 2020

People in the News: Mostafa Ronaghi, Stephen Moore, Alex Aravanis, More

May 06, 2020

Pacific Biosciences Q1 Revenues Down 5 Percent

The sequencing firm reported total revenues of $15.6 million, with instrument revenue negatively impacted by shutdowns precipitated by COVID-19.

May 01, 2020

Illumina Braces for Second Quarter Slowdown Due to COVID-19

Premium

The genomics firm is expecting major revenue decreases in every geographic region but sees signs of hope that business can pick up again later in the year.

Pages

The Scan

Preprints During Lockdown

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

ApoE and COVID-19

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Search for Genetic Clues to COVID-19 Severity

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

PNAS Papers on Retinal Development, Adoptive T Cell Transfer, Blood Cell Differentiation

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.

What's Popular?

In Illumina

  1. Roche Acquires Sequencing Company Stratos Genomics

  2. Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

    Premium

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.